{"title":"蝎子毒液肽在眼科:从巴比伦塔木德的见解。","authors":"David Maskill , Robert Morgan Blizzard","doi":"10.1016/j.ajo.2025.08.054","DOIUrl":null,"url":null,"abstract":"<div><div>Historical medical texts can reveal overlooked therapeutic approaches relevant to modern ophthalmology. This perspective revisits a remedy from the Babylonian Talmud prescribing a mixture of scorpion and kohl for an eye condition called <em>buruqti</em> (also transliterated as <em>beroketi</em>), traditionally translated as cataract. Through philologic, zoologic, and pathologic analysis, we argue that <em>buruqti</em> likely refers to a corneal or conjunctival lesion rather than a true lens opacity. The description within the remedy of the scorpion’s “seven-beaded tail” is interpreted symbolically within the cultural and mystical framework of Late Antiquity. This ancient preparation, although not adopted in later medical texts, raises intriguing possibilities for the use of arachnid venom peptides in ocular disease. These peptides possess antimicrobial, immunomodulatory, and antiangiogenic properties with emerging potential for treating inflammatory and degenerative eye disorders. This article highlights the intersection of historical scholarship and modern biomedical research, suggesting that ancient remedies can inspire novel pharmacologic strategies. We thereby aim to expand the conceptual horizons of ophthalmic drug discovery and encourage exploration of venom-derived peptides as next-generation therapeutics.</div></div>","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":"281 ","pages":"Pages 25-30"},"PeriodicalIF":4.2000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Scorpion Venom Peptides in Ophthalmology: Insights from the Babylonian Talmud\",\"authors\":\"David Maskill , Robert Morgan Blizzard\",\"doi\":\"10.1016/j.ajo.2025.08.054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Historical medical texts can reveal overlooked therapeutic approaches relevant to modern ophthalmology. This perspective revisits a remedy from the Babylonian Talmud prescribing a mixture of scorpion and kohl for an eye condition called <em>buruqti</em> (also transliterated as <em>beroketi</em>), traditionally translated as cataract. Through philologic, zoologic, and pathologic analysis, we argue that <em>buruqti</em> likely refers to a corneal or conjunctival lesion rather than a true lens opacity. The description within the remedy of the scorpion’s “seven-beaded tail” is interpreted symbolically within the cultural and mystical framework of Late Antiquity. This ancient preparation, although not adopted in later medical texts, raises intriguing possibilities for the use of arachnid venom peptides in ocular disease. These peptides possess antimicrobial, immunomodulatory, and antiangiogenic properties with emerging potential for treating inflammatory and degenerative eye disorders. This article highlights the intersection of historical scholarship and modern biomedical research, suggesting that ancient remedies can inspire novel pharmacologic strategies. We thereby aim to expand the conceptual horizons of ophthalmic drug discovery and encourage exploration of venom-derived peptides as next-generation therapeutics.</div></div>\",\"PeriodicalId\":7568,\"journal\":{\"name\":\"American Journal of Ophthalmology\",\"volume\":\"281 \",\"pages\":\"Pages 25-30\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Ophthalmology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0002939425004684\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002939425004684","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Scorpion Venom Peptides in Ophthalmology: Insights from the Babylonian Talmud
Historical medical texts can reveal overlooked therapeutic approaches relevant to modern ophthalmology. This perspective revisits a remedy from the Babylonian Talmud prescribing a mixture of scorpion and kohl for an eye condition called buruqti (also transliterated as beroketi), traditionally translated as cataract. Through philologic, zoologic, and pathologic analysis, we argue that buruqti likely refers to a corneal or conjunctival lesion rather than a true lens opacity. The description within the remedy of the scorpion’s “seven-beaded tail” is interpreted symbolically within the cultural and mystical framework of Late Antiquity. This ancient preparation, although not adopted in later medical texts, raises intriguing possibilities for the use of arachnid venom peptides in ocular disease. These peptides possess antimicrobial, immunomodulatory, and antiangiogenic properties with emerging potential for treating inflammatory and degenerative eye disorders. This article highlights the intersection of historical scholarship and modern biomedical research, suggesting that ancient remedies can inspire novel pharmacologic strategies. We thereby aim to expand the conceptual horizons of ophthalmic drug discovery and encourage exploration of venom-derived peptides as next-generation therapeutics.
期刊介绍:
The American Journal of Ophthalmology is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and visual science specialists describing clinical investigations, clinical observations, and clinically relevant laboratory investigations. Published monthly since 1884, the full text of the American Journal of Ophthalmology and supplementary material are also presented online at www.AJO.com and on ScienceDirect.
The American Journal of Ophthalmology publishes Full-Length Articles, Perspectives, Editorials, Correspondences, Books Reports and Announcements. Brief Reports and Case Reports are no longer published. We recommend submitting Brief Reports and Case Reports to our companion publication, the American Journal of Ophthalmology Case Reports.
Manuscripts are accepted with the understanding that they have not been and will not be published elsewhere substantially in any format, and that there are no ethical problems with the content or data collection. Authors may be requested to produce the data upon which the manuscript is based and to answer expeditiously any questions about the manuscript or its authors.